[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

China Human Insulin Sales Market Report 2021

August 2016 | 104 pages | ID: C6D113CD14AEN
QYResearch

US$ 3,200.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report studies sales (consumption) of Human Insulin in China market, focuses on the top players, with sales, price, revenue and market share for each player, covering
  • Novo Nordisk
  • Sanofi
  • Eli Lilly
  • Bioton
  • Dongbao
  • Gan & Lee
  • TUL
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Fast-acting insulin
  • Intermediate-acting insulin
  • Long-acting insulin
Split by applications, this report focuses on sales, market share and growth rate of Human Insulin in each application, can be divided into
  • Application 1
  • Application 2
  • Application 3
China Human Insulin Sales Market Report 2021

1 HUMAN INSULIN OVERVIEW

1.1 Product Overview and Scope of Human Insulin
1.2 Classification of Human Insulin
  1.2.11 Fast-acting insulin
  1.2.12 Intermediate-acting insulin
  1.2.13 Long-acting insulin
1.3 Applications of Human Insulin
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 China Market Size (Value and Volume) of Human Insulin (2011-2021)
  1.4.1 China Human Insulin Sales, Revenue and Price (2011-2021)
  1.4.2 China Human Insulin Sales and Growth Rate (2011-2021)
  1.4.3 China Human Insulin Revenue and Growth Rate (2011-2021)

2 CHINA HUMAN INSULIN COMPETITION BY MANUFACTURERS

2.1 China Human Insulin Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 China Human Insulin Revenue and Share by Manufactures (2015 and 2016)

3 CHINA HUMAN INSULIN (VOLUME AND VALUE) BY TYPE

3.1 China Human Insulin Sales and Market Share by Type (2011-2021)
3.2 China Human Insulin Revenue and Market Share by Type (2011-2021)

4 CHINA HUMAN INSULIN (VOLUME) BY APPLICATION

5 CHINA HUMAN INSULIN MANUFACTURERS ANALYSIS

5.1 Novo Nordisk
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Human Insulin Product Type and Technology
    5.1.2.1 Fast-acting insulin
    5.1.2.2 Intermediate-acting insulin
  5.1.3 Human Insulin Sales, Revenue, Price of Novo Nordisk (2015 and 2016)
5.2 Sanofi
  5.2.1 Company Basic Information,Manufacturing Base and Competitors
  5.2.2 Medicine Product Type and Technology
    5.2.2.1 Fast-acting insulin
    5.2.2.2 Intermediate-acting insulin
  5.2.3 Medicine Sales, Revenue, Price of Sanofi (2015 and 2016)
5.3 Eli Lilly
  5.3.1 Company Basic Information,Manufacturing Base and Competitors
  5.3.2 Eli Lilly Product Type and Technology
    5.3.2.1 Fast-acting insulin
    5.3.2.2 Intermediate-acting insulin
  5.3.3 Eli Lilly Sales, Revenue, Price of Eli Lilly (2015 and 2016)
5.4 Bioton
  5.4.1 Company Basic Information,Manufacturing Base and Competitors
  5.4.2 Product Type and Technology
    5.4.2.1 Fast-acting insulin
    5.4.2.2 Intermediate-acting insulin
  5.4.3 Bioton Sales, Revenue, Price of Bioton (2015 and 2016)
5.5 Dongbao
  5.5.1 Company Basic Information,Manufacturing Base and Competitors
  5.5.2 Dongbao Product Type and Technology
    5.5.2.1 Fast-acting insulin
    5.5.2.2 Intermediate-acting insulin
  5.5.3 Dongbao Sales, Revenue, Price of Dongbao (2015 and 2016)
5.6 Gan & Lee
  5.6.1 Company Basic Information,Manufacturing Base and Competitors
  5.6.2 Gan & Lee Product Type and Technology
    5.6.2.1 Fast-acting insulin
    5.6.2.2 Intermediate-acting insulin
  5.6.3 Gan & Lee Sales, Revenue, Price of Gan & Lee (2015 and 2016)
5.7 TUL
  5.7.1 Company Basic Information,Manufacturing Base and Competitors
  5.7.2 TUL Product Type and Technology
    5.7.2.1 Fast-acting insulin
    5.7.2.2 Intermediate-acting insulin
  5.7.3 TUL Sales, Revenue, Price of TUL (2015 and 2016)

6 HUMAN INSULIN TECHNOLOGY AND DEVELOPMENT TREND

6.1 Human Insulin Technology Analysis
6.2 Human Insulin Technology Development Trend

7 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES AND FIGURES

Figure Picture of Human Insulin
Table Classification of Human Insulin
Figure China Sales Market Share of Human Insulin by Type in 2015
Figure Fast-acting insulin Picture
Figure Intermediate-acting insulin Picture
Figure Long-acting insulin Picture
Table Applications of Human Insulin
Figure China Sales Market Share of Human Insulin by Application in 2015
Table China Human Insulin Sales, Revenue and Price (2011-2021)
Figure China Human Insulin Sales and Growth Rate (2011-2021)
Figure China Human Insulin Revenue and Growth Rate (2011-2021)
Table China Human Insulin Sales of Key Manufacturers (2015 and 2016)
Table China Human Insulin Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Human Insulin Sales Share by Manufacturers
Figure 2016 Human Insulin Sales Share by Manufacturers
Table China Human Insulin Revenue by Manufacturers (2015 and 2016)
Table China Human Insulin Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Human Insulin Revenue Share by Manufacturers
Table 2016 China Human Insulin Revenue Share by Manufacturers
Table China Human Insulin Sales and Market Share by Type (2011-2021)
Table China Human Insulin Sales Share by Type (2011-2021)
Figure Sales Market Share of Human Insulin by Type (2011-2021)
Figure China Human Insulin Sales Growth Rate by Type (2011-2021)
Table China Human Insulin Revenue and Market Share by Type (2011-2021)
Table China Human Insulin Revenue Share by Type (2011-2021)
Figure Revenue Market Share of Human Insulin by Type (2011-2021)
Figure China Human Insulin Revenue Growth Rate by Type (2011-2021)
Table China Human Insulin Sales and Market Share by Application (2011-2021)
Table China Human Insulin Sales Share by Application (2011-2021)
Figure Sales Market Share of Human Insulin by Application (2011-2021)
Figure China Human Insulin Sales Growth Rate by Application (2011-2021)
Table Novo Nordisk Basic Information List
Table Human Insulin Sales, Revenue, Price of Novo Nordisk (2015 and 2016)
Table Sanofi Basic Information List
Table Human Insulin Sales, Revenue, Price of Sanofi (2015 and 2016)
Table Eli Lilly Basic Information List
Table Human Insulin Sales, Revenue, Price of Eli Lilly (2015 and 2016)
Table Bioton Basic Information List
Table Human Insulin Sales, Revenue, Price of Bioton (2015 and 2016)
Table Dongbao Basic Information List
Table Human Insulin Sales, Revenue, Price of Dongbao (2015 and 2016)
Table Gan & Lee Basic Information List
Table Human Insulin Sales, Revenue, Price of Gan & Lee (2015 and 2016)
Table TUL Basic Information List
Table Human Insulin Sales, Revenue, Price of TUL (2015 and 2016)


More Publications